Dr. Dario Siniscalco is biochemist for the Department of Experimental Medicine of the University of Campania, Italy. He graduated in Chemistry from the University of Naples “Federico II” in 2000 and received his Ph.D. in Pharmacological Sciences from the Second University of Naples in 2004. He completed his neuropathology fellowship at University of Alabama at Birmingham, USA before joining the Second University of Naples staff in 2006. He is registered member of the following scientific societies: Order of the Chemists of Campania, National Council for Chemistry, Stem Cell Research Italy, International Association of Neurorestoratology, European Association for Chemical and Molecular Sciences, Italian Pharmacological Society, Cell Death Research Group - University of Alabama at Birmingham, USA.
In 2010, in collaboration with dr. Nicola Antonucci, he founded a research group to study cellular and molecular changes in autism spectrum disorders. Author or co-author of 87 scientific peer-reviewed papers and 10 book chapters. His works received more than 1950 citations so far (h-index 28). Presented 95 communications/abstracts to national and international conferences. He is serving as an editorial board member and reviewer of more than 65 international journals.
His main research interests: gene expression and molecular regulation in autism spectrum disorders; use of stem cells as therapeutic tool in autism; role of monocyte/macrophage activation in autism. Other research interests: stem cells therapy for the neuronal recovery; studying of neuronal apoptosis. Role of bcl-2 family, caspases, and cell cycle regulator genes.
He has been nominated as Editor-in-Chief of the international peer-reviewed journal Autism OpenAccess, Omics group.
Full publication list is here: http://orcid.org/0000-0002-3779-2596